Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Endometrial Neoplasms × atezolizumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 27 Triple Negative Breast Neoplasms 13 Carcinoma, Transitional Cell 12 Breast Neoplasms 12 Urinary Bladder Neoplasms 11 Small Cell Lung Carcinoma 10 Neoplasms 8 Melanoma 8 Carcinoma, Hepatocellular 6 Neoplasm Metastasis 5 Lung Neoplasms 5 Uterine Cervical Neoplasms 4 Ovarian Neoplasms 4 Lymphoma 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Recurrence 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Brain Neoplasms 3 Solid Tumors 2 Prostatic Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Carcinoma 2 Biliary Tract Neoplasms 2 Uterine Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1

Interventions

pembrolizumab 14 Paclitaxel 14 Carboplatin 10 Bevacizumab 6 rucaparib 5 lenvatinib 5 Megestrol Acetate 5 Radiation 4 Nivolumab 4 Indocyanine Green 4 tisotumab vedotin 3 temsirolimus 3 Sirolimus 3 Sentinel Lymph Node Biopsy 3 Doxorubicin 3 olaparib 2 ixabepilone 2 iso-sulfan blue 2 irosustat 2 epacadostat 2 durvalumab 2 copanlisib 2 Taxes 2 Metformin 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Ipilimumab 2 Gemcitabine 2 Fulvestrant 2 Cisplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03694262 2025-05-30

EndoBARR

Medical College of Wisconsin

Phase 2 Active not recruiting

30 enrolled 7 charts

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡